Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2000
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010547A2 New use of taxoid derivatives
03/02/2000WO2000010543A2 Medicament containing platinum complex compounds and the use thereof
03/02/2000WO2000010507A2 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000WO1999063945A3 Vaccination strategy to prevent and treat cancers
03/02/2000WO1999062909A3 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999059640A3 Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999058552A3 Peptides that ellicit t, cellular immunity
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000WO1999055377A9 Polyol-ifn-beta conjugates
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999047668A3 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999036535A9 Apo-2 ligand
03/02/2000DE19826517A1 Cyclophosphamid-Filmtabletten Cyclophosphamide tablets
03/02/2000DE19814405C2 Porphyrine und ihre Verwendung als Photosensitizer Porphyrins and their use as photosensitizer
03/02/2000CA2342503A1 Quinazoline derivatives
03/02/2000CA2341903A1 Use of melanin for inhibition of angiogenesis and macular degeneration
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341701A1 Medicament containing platinum complex compounds and the use thereof
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341234A1 Water soluble analogs and prodrugs of paclitaxel
03/02/2000CA2341191A1 New use of taxoid derivatives
03/02/2000CA2340929A1 Methods to enhance and confine expression of genes
03/02/2000CA2340785A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000CA2340616A1 Secreted proteins and polynucleotides encoding them
03/02/2000CA2340459A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340456A1 Lats knock-out animal models and their uses
03/02/2000CA2340334A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339860A1 Human cell signaling proteins (csig)
03/02/2000CA2339775A1 Vitamin d3 mimics
03/02/2000CA2339537A1 Regulation of substrate activity
03/02/2000CA2338837A1 Assays, methods and means for modulating nuclear localisation
03/02/2000CA2337905A1 Targeted alphavirus and alphaviral vectors
03/01/2000EP0982405A2 Recombinant alphavirus vectors
03/01/2000EP0982308A1 Derivatives of the 8H-(2,3-b)-pyrrolizine-8-one, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents
03/01/2000EP0982036A1 Modulation of Beta2 -integrin-mediated cell adhesion
03/01/2000EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
03/01/2000EP0981648A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
03/01/2000EP0981620A1 Hgf polypeptides and their use in therapy
03/01/2000EP0981618A1 Apo-2 RECEPTOR
03/01/2000EP0981610A2 Compositions for treatment of disorders involving programmed cell death
03/01/2000EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
03/01/2000EP0981547A1 Tumor-associated antigen
03/01/2000EP0981542A1 20(s) camptothecin glycoconjugates
03/01/2000EP0981541A1 Psca: prostate stem cell antigen
03/01/2000EP0981539A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus
03/01/2000EP0981538A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders
03/01/2000EP0981519A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
03/01/2000EP0981517A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
03/01/2000EP0981377A1 Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof
03/01/2000EP0981376A1 Targeted therapeutic delivery of vitamin d compounds
03/01/2000EP0981375A1 Pharmaceutical compositions containing plasma protein
03/01/2000EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
03/01/2000EP0981365A1 Leptin as an inhibitor of tumor cell proliferation
03/01/2000EP0981358A1 Dolastatin-15 derivatives in combination with taxanes
03/01/2000EP0981350A1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol
03/01/2000EP0981349A1 Pregnan-3-ol-20-ones
03/01/2000EP0981342A2 Method and composition for treating cancers
03/01/2000EP0981341A1 Use of betulinic acid derivatives for the treatment and prevention of melanoma
03/01/2000EP0981338A1 ORAL PREPARATION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF $i(HELICOBACTER SP.) INFECTION
03/01/2000EP0981327A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
03/01/2000EP0981276A1 6-halo-or nitrate-substituted paclitaxels
03/01/2000EP0804445B1 Metallocenic diarylethylene derivatives, methods for their preparation and pharmaceutical compositions containing same
03/01/2000EP0680365B1 Activation of photosensitive agents
03/01/2000EP0594739B1 Cancer treatment
03/01/2000CN1245720A Medicinal composition containing calcineurin B subunit
03/01/2000CN1245707A Chinese medicine for curing AIDS and carcinomatosis
03/01/2000CN1245693A Chinese medicine powder Kangfusan for curing leukemia
03/01/2000CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound
03/01/2000CN1049820C Etoposide preparations
03/01/2000CA2246791A1 Treatment of endothelium with somatostatin analogues
02/2000
02/29/2000US6031135 Protein kinase-c activity; antitumor agents, antiinflammatory agents, preservatives; treating thrombosis
02/29/2000US6031133 Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
02/29/2000US6031072 Compounds and methods for modulating cell adhesion
02/29/2000US6031001 Topical treatment of psoriasis by applying to the skin a composition comprising prostalandin a2 or j2, or a derivative or an alkyl or benzyl ester of either; antiproliferative agents
02/29/2000US6031000 Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
02/29/2000US6030994 Substituted pyrroles compositions
02/29/2000US6030982 Analogs of a 4-(2-((3,10-dibromo-8-chloro-4-(2-((3,10-dibromo-8-chloro-6,11 -dihydro-5h-benzo(5,6)-cyclohepta(1,2-b)pyrid-11-yl)-1-piperidinyl)-2 -oxothyl-betaoxo-1-piperidine; antitumor agents
02/29/2000US6030981 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
02/29/2000US6030975 Carboxylic acid derivatives, their preparation and use in treating cancer
02/29/2000US6030963 For treating neoplastic diseases such as leukemia
02/29/2000US6030961 Oxyalkylene phosphate compounds and uses thereof
02/29/2000US6030946 Reversible cysteine protease inhibitors
02/29/2000US6030945 Apo-2 ligand
02/29/2000US6030831 Tie ligand homologues
02/29/2000US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
02/29/2000US6030801 Amino acid sequence of enzyme; for screening a library for molecules which bind the polypeptide; diagnosis, treatment or prevention of cancer, immune and reproductive disorders; anticarcinogenic agents
1 ... 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 1936 1937 1938 1939 1940 1941 1942 ... 2211